Marpai, Inc. (MRAI)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Marpai, Inc. (MRAI) with AI Score 40/100 (Weak). Marpai, Inc. operates as a technology-driven healthcare payer, focusing on the self-insured employer market in the United States and Israel. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 18, 2026Marpai, Inc. (MRAI) Healthcare & Pipeline Overview
Marpai, Inc. provides technology-driven healthcare payment solutions to self-insured employers, utilizing AI for predictive analysis and cost containment. The company operates in the competitive healthcare plans sector, offering ancillary services and focusing on the US and Israeli markets.
Investment Thesis
Marpai, Inc. presents an investment case centered on its technology-driven approach to healthcare payment solutions for self-insured employers. The company's AI-powered platform aims to reduce healthcare costs and improve outcomes, potentially driving revenue growth. A key value driver is the expansion of its client base within the self-insured employer market. Upcoming catalysts include the further development and deployment of its AI capabilities. However, potential risks include the company's negative profit margin of -58.4% and the need to secure additional funding to sustain operations. The high beta of 4.69 suggests significant volatility.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.01 billion reflects its small size within the healthcare sector.
- A P/E ratio of -0.70 indicates the company is currently not profitable.
- Gross margin of 30.7% demonstrates the company's ability to generate revenue above the direct cost of services.
- Profit margin of -58.4% highlights significant challenges in achieving profitability.
- Beta of 4.69 suggests the stock is highly volatile compared to the broader market.
Competitors & Peers
Strengths
- Technology-driven approach with AI platform.
- Focus on the self-insured employer market.
- Comprehensive suite of ancillary services.
- Operations in both the United States and Israel.
Weaknesses
- Negative profit margin.
- Small market capitalization.
- High beta indicating significant volatility.
- Reliance on securing additional funding.
Catalysts
- Further development and deployment of its AI capabilities to enhance predictive healthcare solutions.
- Expansion within the self-insured employer market through targeted marketing and partnerships.
- Strategic partnerships and acquisitions to expand service offerings and market reach.
Risks
- Negative profit margin of -58.4% indicates financial instability.
- Need to secure additional funding to sustain operations.
- High beta of 4.69 suggests significant stock volatility.
- Competition from established healthcare providers and technology companies.
- Regulatory changes in the healthcare industry affecting business operations.
Growth Opportunities
- Expansion within the Self-Insured Employer Market: The self-insured employer market is expanding as companies seek greater control over healthcare costs. Marpai can capitalize on this trend by increasing its client base through targeted marketing and partnerships. The US self-insured market is estimated to cover over 60% of employees, representing a substantial opportunity for growth. Timeline: Ongoing.
- Development and Deployment of AI-Driven Solutions: Marpai's investment in AI and healthcare technology offers significant growth potential. By enhancing its platform's predictive capabilities and expanding its AI-driven services, the company can attract new clients and increase revenue from existing customers. The market for AI in healthcare is projected to reach $34 billion by 2025. Timeline: Ongoing.
- Geographic Expansion into New Markets: While currently focused on the United States and Israel, Marpai can explore opportunities to expand its services into new geographic markets. This could involve targeting countries with similar healthcare systems or partnering with local providers to offer its solutions. The global healthcare market is vast, with significant potential for growth in emerging economies. Timeline: 2027-2028.
- Strategic Partnerships and Acquisitions: Marpai can pursue strategic partnerships and acquisitions to expand its service offerings and market reach. This could involve partnering with other healthcare providers, technology companies, or actuarial firms. Strategic alliances can provide access to new markets, technologies, and expertise. Timeline: Ongoing.
- Enhancement of Ancillary Services: Marpai offers a range of ancillary services, including care management, case management, and health savings account administration. By enhancing these services and integrating them more closely with its AI-driven platform, the company can provide a more comprehensive and valuable solution to its clients. The market for healthcare ancillary services is growing, driven by the increasing complexity of healthcare delivery. Timeline: Ongoing.
Opportunities
- Expansion within the self-insured employer market.
- Development and deployment of AI-driven solutions.
- Geographic expansion into new markets.
- Strategic partnerships and acquisitions.
Threats
- Competition from established healthcare providers.
- Regulatory changes in the healthcare industry.
- Economic pressures affecting healthcare spending.
- Technological advancements by competitors.
Competitive Advantages
- Proprietary AI-driven platform for healthcare data analysis.
- Focus on the self-insured employer market.
- Comprehensive suite of ancillary services.
About MRAI
Marpai, Inc., incorporated in 2021 and headquartered in New York City, is a technology-driven healthcare payer operating in the self-insured employer market across the United States and Israel. The company's core focus is leveraging artificial intelligence and healthcare technology to analyze data, predict potential healthcare events, and prevent diagnostic errors, hospital visits, and administrative inefficiencies. Marpai offers a suite of ancillary services, including care management, case management, actuarial services, health savings account administration, and cost containment solutions. Marpai's business model centers around providing comprehensive healthcare solutions to self-insured employers, enabling them to manage healthcare costs more effectively while improving employee health outcomes. The company's AI-driven platform aims to provide insights that lead to proactive healthcare interventions and better resource allocation. By focusing on the self-insured market, Marpai targets employers who directly bear the financial risk of their employees' healthcare expenses, creating a demand for cost-effective and data-driven solutions. The company aims to differentiate itself through its technology platform and comprehensive service offerings within the healthcare payer landscape.
What They Do
- Provides healthcare payment solutions to self-insured employers.
- Offers ancillary services such as care management and actuarial services.
- Develops AI and healthcare technology for data analysis.
- Predicts and prevents events related to diagnostic errors.
- Aims to reduce hospital visits and administrative issues.
- Operates in the United States and Israel.
Business Model
- Generates revenue by providing healthcare payment solutions to self-insured employers.
- Offers ancillary services for additional revenue streams.
- Leverages AI to improve healthcare outcomes and reduce costs for clients.
Industry Context
Marpai, Inc. operates within the healthcare plans industry, a segment characterized by increasing demand for cost-effective and data-driven solutions. The self-insured employer market is growing as companies seek greater control over healthcare spending. The industry is competitive, with established players and emerging technology-driven companies vying for market share. Marpai's focus on AI and data analytics positions it to capitalize on the trend towards personalized and preventative healthcare. The healthcare sector is subject to regulatory changes and economic pressures, influencing the competitive landscape.
Key Customers
- Self-insured employers in the United States.
- Self-insured employers in Israel.
Financials
Chart & Info
Marpai, Inc. (MRAI) stock price: Price data unavailable
Latest News
-
Insurance Stocks Moving In Monday's Intraday Session
benzinga · Sep 4, 2023
-
Insurance Stocks Moving In Thursday's Intraday Session
benzinga · Aug 17, 2023
-
Stocks That Hit 52-Week Lows On Wednesday
benzinga · Aug 9, 2023
-
Insurance Stocks Moving In Wednesday's Intraday Session
benzinga · Aug 2, 2023
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MRAI.
Price Targets
Wall Street price target analysis for MRAI.
MoonshotScore
What does this score mean?
The MoonshotScore rates MRAI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Leadership: Damien Francis Lamendola
CEO
Damien Francis Lamendola serves as the CEO of Marpai, Inc., bringing experience in healthcare management and technology. His background includes leadership roles in various healthcare organizations, focusing on innovation and strategic growth. He is responsible for overseeing Marpai's operations, driving its technology development, and expanding its market presence. Lamendola's expertise lies in leveraging technology to improve healthcare outcomes and reduce costs for self-insured employers.
Track Record: Under Damien Francis Lamendola's leadership, Marpai, Inc. has focused on developing its AI-driven platform and expanding its service offerings. Key milestones include securing partnerships with self-insured employers and enhancing the company's technology infrastructure. Lamendola has been instrumental in driving Marpai's strategic direction and positioning it as a technology-driven healthcare payer.
MRAI OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Marpai, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, leading to increased risks for investors. This tier is often associated with speculative investments and requires careful due diligence.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure due to OTC Other tier status.
- Potential for low trading volume and liquidity.
- Increased price volatility.
- Higher risk of fraud or manipulation compared to listed exchanges.
- Limited regulatory oversight.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Monitor trading volume and price volatility.
- Understand the risks associated with OTC investments.
- Consult with a financial advisor.
- Company operates in the healthcare sector, providing services to self-insured employers.
- CEO has experience in healthcare management and technology.
- Development of an AI-driven platform for healthcare data analysis.
- Focus on improving healthcare outcomes and reducing costs for clients.
Marpai, Inc. Healthcare Stock: Key Questions Answered
What does Marpai, Inc. do?
Marpai, Inc. is a technology-driven healthcare payer that focuses on providing solutions to the self-insured employer market in the United States and Israel. The company leverages artificial intelligence and healthcare technology to analyze data, predict potential healthcare events, and prevent diagnostic errors, hospital visits, and administrative inefficiencies. Marpai offers a suite of ancillary services, including care management, case management, actuarial services, health savings account administration, and cost containment solutions, aiming to improve healthcare outcomes and reduce costs for its clients.
What do analysts say about MRAI stock?
AI analysis is pending for MRAI, and therefore, analyst ratings are unavailable. Key valuation metrics to consider include the company's market capitalization of $0.01 billion, negative P/E ratio of -0.70, and gross margin of 30.7%. Growth considerations center on the company's ability to expand its client base, develop its AI capabilities, and achieve profitability. The high beta of 4.69 suggests significant volatility, requiring careful risk management.
What are the main risks for MRAI?
The main risks for Marpai, Inc. include its negative profit margin of -58.4%, indicating financial instability and the need to secure additional funding. The company faces competition from established healthcare providers and technology companies. Regulatory changes in the healthcare industry could also impact its business operations. The high beta of 4.69 suggests significant stock volatility, requiring investors to carefully manage their risk exposure. As an OTC stock, MRAI faces additional risks related to liquidity and disclosure.
How does Marpai, Inc. leverage AI in its healthcare solutions?
Marpai, Inc. utilizes AI to analyze healthcare data, predict potential healthcare events, and prevent diagnostic errors, hospital visits, and administrative inefficiencies. The company's AI-driven platform aims to provide insights that lead to proactive healthcare interventions and better resource allocation for self-insured employers. By leveraging AI, Marpai seeks to improve healthcare outcomes, reduce costs, and provide a more personalized and efficient healthcare experience for its clients and their employees. The specific applications of AI are pending further analysis.
What revenue streams does Marpai, Inc. have in healthcare?
Marpai, Inc. generates revenue primarily through providing healthcare payment solutions to self-insured employers in the United States and Israel. Additional revenue streams include fees for ancillary services such as care management, case management, actuarial services, health savings account administration, and cost containment solutions. The company's revenue model is based on providing comprehensive healthcare solutions that improve outcomes and reduce costs for its clients. Specific revenue breakdowns are not available.
What are the key factors to evaluate for MRAI?
Marpai, Inc. (MRAI) currently holds an AI score of 40/100, indicating low score. Key strength: Technology-driven approach with AI platform. Primary risk to monitor: Negative profit margin of -58.4% indicates financial instability. This is not financial advice.
How frequently does MRAI data refresh on this page?
MRAI prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven MRAI's recent stock price performance?
Recent price movement in Marpai, Inc. (MRAI) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Technology-driven approach with AI platform. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial information available due to OTC Other tier status.
- AI analysis pending for MRAI.